Dolly was born on 5 July 1996 and became the first mammal cloned from an adult somatic cell, a milestone that challenged prevailing scientific assumptions. The cloning process involved nuclear transfer from a sheep cell into an enucleated egg, confirming that adult cells could give rise to a fully formed organism.
The announcement sparked mixed reactions among scientists, with some experts questioning the validity of the claim and others intrigued by its potential applications. The debate highlighted the limits of current knowledge at the time.
Ethical concerns quickly followed, as the possibility of extending cloning to humans raised questions about safety, identity, and moral responsibility. Political leaders called for regulation, including a request for a federal funding ban on human cloning, though no such ban has been enacted.
The research team at the Roslin Institute maintained that their goal was to advance medical science, not to create human clones. Findings were intended to improve disease models and regenerative therapies, and the institute discontinued cloning experiments after Dolly’s death.
Dolly’s success opened the door to cloning other species, including horses for racing and polo, and commercial programs for pet reproduction. The technique has been applied to livestock to
